Elite Pharmaceuticals, Inc.
ELTP · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$4,315 | $20,109 | $3,562 | $8,898 |
| Dep. & Amort. | $2,122 | $1,472 | $1,345 | $1,435 |
| Deferred Tax | $3,795 | -$19,989 | $1,509,616 | -$2,172 |
| Stock-Based Comp. | $228 | $8,514 | $579 | $781 |
| Change in WC | -$15,166 | -$11,881 | -$2,026 | -$1,010 |
| Other Non-Cash | $20,792 | -$1,506 | -$1,509,738 | -$1,424 |
| Operating Cash Flow | $7,456 | -$3,282 | $3,339 | $6,508 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,625 | -$810 | -$5,737 | -$499 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$775 | $0 | $0 | $0 |
| Investing Cash Flow | -$2,400 | -$810 | -$5,737 | -$499 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$845 | $3,339 | $1,702 | -$667 |
| Stock Issued | $19 | $159,921 | $39,325 | $14,353 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $46 | $0 | $0 |
| Financing Cash Flow | -$826 | $3,386 | $1,702 | -$667 |
| Forex Effect | $0 | $0 | -$695,019 | $0 |
| Net Chg. in Cash | $4,230 | -$706 | -$696 | $5,343 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $7,539 | $8,245 | $8,940 | $3,598 |
| End Cash | $11,769 | $7,539 | $8,245 | $8,940 |
| Free Cash Flow | $4,931 | -$4,091 | -$2,398 | $6,010 |